Lipidomic	O
Signatures	O
and	O
Associated	O
Transcriptomic	O
Profiles	O
of	O
Clear	B:C0279702
Cell	I:C0279702
Renal	I:C0279702
Cell	I:C0279702
Carcinoma	I:C0279702
.	O

Renal	B:C0007134
cell	I:C0007134
carcinoma	I:C0007134
(	O
RCC	B:C0007134
)	I:C0007134
is	O
the	O
most	O
common	O
histological	B:C0449574
type	I:C0449574
of	O
adult	O
kidney	B:C1378703
cancer	I:C1378703
.	O

In	O
this	O
study	B:C2603343
,	O
we	O
obtained	O
lipidomic	O
profiles	O
of	O
clear	B:C0279702
cell	I:C0279702
RCC	I:C0279702
(	O
clear	B:C0279702
cell	I:C0279702
RCC	I:C0279702
)	O
,	O
a	O
major	O
Renal	B:C0007134
cell	I:C0007134
carcinoma	I:C0007134
subtype	B:C0449560
,	O
by	O
performing	O
a	O
lipidomic	O
analysis	O
of	O
specimens	O
of	O
cancerous	B:C0027656
tissue	I:C0027656
and	O
the	O
surrounding	O
normal	O
renal	B:C0022655
cortex	I:C0022655
obtained	O
from	O
the	O
same	O
patients	O
(	O
N	O
=	O
49	O
)	O
.	O

We	O
also	O
compared	O
the	O
lipidomic	O
profiles	O
with	O
the	O
lipogenic	O
transcriptome	B:C3178810
of	O
specimens	O
of	O
cancerous	B:C0027656
tissue	I:C0027656
and	O
the	O
surrounding	O
normal	O
renal	B:C0022655
cortex	I:C0022655
for	O
an	O
additional	O
set	O
of	O
patient	O
samples	O
(	O
N	O
=	O
95	O
)	O
.	O

Overall	O
,	O
we	O
detected	O
326	O
lipids	B:C0023779
,	O
including	O
phospholipids	B:C0031676
,	O
sphingolipids	B:C0037900
,	O
neutral	B:C0023779
lipids	I:C0023779
,	O
and	O
eicosanoids	B:C0013725
.	O

The	O
levels	O
of	O
more	O
than	O
70	O
%	O
of	O
the	O
detected	O
lipids	B:C0023779
were	O
significantly	O
different	O
(	O
P	O
<	O
0.01	O
,	O
corrected	O
by	O
the	O
false	O
discovery	O
rate	O
)	O
.	O

The	O
cancerous	B:C0027656
tissue	I:C0027656
was	O
distinguished	O
by	O
higher	O
levels	O
of	O
ether	B:C0031676
-	I:C0031676
type	I:C0031676
phospholipids	I:C0031676
,	O
cholesterol	B:C0008387
esters	I:C0008387
,	O
and	O
triacylglycerols	B:C0041004
,	O
as	O
well	O
as	O
by	O
lower	O
levels	O
of	O
phospholipids	B:C0031676
(	O
except	O
for	O
phosphatidylcholines	B:C1959616
)	O
and	O
polyunsaturated	B:C0032615
fatty	I:C0032615
acids	I:C0032615
.	O

Characteristic	O
changes	O
in	O
the	O
levels	O
of	O
mRNAs	B:C0035696
and	O
metabolites	B:C0870883
suggested	O
that	O
the	O
phosphatidylethanolamine	B:C1156439
(	I:C1156439
PE	I:C1156439
)	I:C1156439
synthesis	I:C1156439
pathway	I:C1156439
is	O
suppressed	O
in	O
clear	B:C0279702
cell	I:C0279702
RCC	I:C0279702
and	O
associated	O
with	O
cell	B:C0596290
proliferation	I:C0596290
.	O

The	O
present	O
study	B:C2603343
represents	O
the	O
lipidomic	O
profiles	O
of	O
clear	B:C0279702
cell	I:C0279702
RCC	I:C0279702
,	O
which	O
provides	O
novel	O
information	O
about	O
the	O
metabolic	B:C0025519
changes	O
in	O
renal	B:C0022646
cancerous	B:C0027656
tissue	I:C0027656
and	O
Renal	B:C0007134
cell	I:C0007134
carcinoma	I:C0007134
pathophysiology	B:C0277785
.	O

